|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11,988 GBX | -0.32% |
|
+9.52% | +13.09% |
| Apr. 26 | ASTRAZENECA : DZ Bank sticks Neutral | ZD |
| Apr. 26 | ASTRAZENECA : UBS keeps a Sell rating | ZD |
BRUSSELS, Oct 29 (Reuters) - The European Commission is in talks with four companies to secure a potential COVID-19 vaccine, President Ursula von der Leyen said on Thursday following an EU leaders' video conference.
The EU has already secured potential vaccines being developed by AstraZeneca, Sanofi and Johnson & Johnson. It has also said to be in talks with Moderna, CureVac and a partnership of Pfizer and BionTech. (Reporting by Brussels newsroom)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 108 USD | +1.69% | +6.47% | 40.65B | ||
| 91.23 EUR | -0.43% | +4.99% | 123B | ||
| 25.4 USD | +0.55% | -2.31% | 143B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +13.09% | 233B | |
| +25.83% | 653B | |
| +27.00% | 556B | |
| -6.76% | 354B | |
| +20.34% | 331B | |
| +3.00% | 296B | |
| +5.46% | 201B | |
| -9.61% | 193B | |
| -6.26% | 144B | |
| -11.77% | 143B |
ASTRAZENECA PLC 
